Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19Interleukin-18은 COVID-19에서 활성 성인 발병 스틸병을 구별하는 잠재적 바이오마커입니다Immunology Published on 2021-07-232022-09-11 Journal: Frontiers in Immunology [Category] SARS, 바이오마커, [키워드] Accuracy adult-onset Still’s disease (AOSD) AUC Biomarker Biomarkers clinical feature COVID-19 COVID-19 patient cross-sectional cross-sectional study cut-off value cytokine cytokine profile Cytokine storm Cytokines determined by develop disease Diseases dysregulated elevated ELISA examined feature ferritin ferritin level galectin-3 Galectin-9 galectins healthy control highest hyperinflammation identify IFN-α2 IFN-γ IL-10 IL-17A IL-18 IL-1ra IL-1β IL-6 immunochromatographic assay Interleukin-18 multivariate regression analysis Patient patients plasma Plasma levels platform Potential predict Result SARS-CoV-2 sensitivity Seropositivity severe COVID-19 severe COVID-19 patient severe COVID-19 patients significantly significantly higher specificity TNF-α [DOI] 10.3389/fimmu.2021.719544 PMC 바로가기 [Article Type] Immunology
Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL StudyArticle Published on 2021-07-212022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] age Analysis anti-SARS-CoV-2 antibody antibodies antibody Asymptomatic average Chemiluminescent assay Community Complete conducted COVID-19 COVID-19 pandemic cross-sectional described diagnoses effective evaluate Factor female Fever highest hygiene IgG and IgM IgG antibody Loss of Smell measure New pandemic participant Prevalence principal public health measures quantified questionnaire Salamanca SARS-CoV-2 SARS-CoV-2 antibody Screening seropositive participant Seropositivity Seroprevalence significant difference Spain Spread Surveillance Symptom the SARS-CoV-2 university [DOI] 10.3390/jcm10153214 PMC 바로가기 [Article Type] Article
Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assaysSARS-COV-2 항체의 동역학 및 혈청 유병률 : 3 가지 다른 분석법의 비교Comparative Study Published on 2021-07-212022-09-01 Journal: Scientific Reports [Category] SARS, 진단, 치료기술, [키워드] Abbott Abbott Diagnostics analyzed antibody antibody kinetics assays baseline COVID-19 patient DiaSorin Euroimmun Follow-up Infection Kinetics LIAISON Medical research Molecular medicine SARS-CoV-2 SARS-CoV-2 antibody Seropositivity Seroprevalence significant difference significant differences significantly [DOI] 10.1038/s41598-021-94453-5 PMC 바로가기 [Article Type] Comparative Study
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia의뢰 병원 및 검역소에서 전염병 피크 동안 의료 종사자의 SARS-COV-2 결합 및 중화 항체의 혈청 유병률 : 사우디 아라비아Article Published on 2021-07-202022-09-01 Journal: Viruses [Category] SARS, 진단, 치료기술, [키워드] 95% CI anti-S Abs Asymptomatic city collected compatible symptom compatible symptoms COVID-19 COVID-19 epidemic COVID-19 pandemic cross-sectional diagnosed with COVID-19 evaluate General Hospital General population HCW HCWs healthcare worker Healthcare workers high risk hospital Jeddah participant peak proportion quarantine Randomly recruited Referral SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection Saudi Arabia seropositive Seropositivity Seroprevalence significantly Study design the SARS-CoV-2 worker [DOI] 10.3390/v13071413 PMC 바로가기 [Article Type] Article
Longitudinal Serology of SARS-CoV-2-Infected Individuals in India: A Prospective Cohort Study인도에서 SARS-COV-2- 감염된 개인의 종단 혈청학 : 전향 적 코호트 연구Articles Published on 2021-07-182022-09-10 Journal: The American Journal of Tropical Medicine and Hygi [Category] SARS, 진단, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 All participant All participants Antigen Asia Asymptomatic Capital Capital Region Characteristics clinical cohorts comparable convalescence coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 epidemiological highlight humoral immune response IgG IgG antibodies IgG antibody immune responses Immunoglobulin Immunoglobulin G immunological characteristics India individual Infection longitudinal Mild mild to moderate moderate multivariable Multivariable regression analysis nasopharyngeal viral nucleocapsid participant positive individuals Postinfection predictor proportion Prospective prospective cohort RBD RBD antigen Receptor binding domain Region regression analysis respiratory response RNA RT-PCR RT-PCR SARS-CoV-2 SARS-CoV-2-positive individual Seroconversion seroconversion rate seroconversion rates serological response serology Seropositivity Serosurveys severe acute respiratory syndrome Coronavirus severe disease severity South subset symptomatic the RBD threshold value Viral were assessed [DOI] 10.4269/ajtmh.21-0164 PMC 바로가기 [Article Type] Articles
SARS-CoV-2 in Rural Latin America. A Population-based Study in Coastal Ecuador농촌 라틴 아메리카의 SARS-CoV-2. 해안 에콰도르의 인구 기반 연구Article Published on 2021-07-152022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 can not clinical manifestations coronavirus Coronavirus-19 Ecuador Latin America population study Rural setting SARS-CoV-2 Seropositivity severe acute respiratory syndrome Coronavirus Spread Support Transmission [DOI] 10.1093/cid/ciaa1055 PMC 바로가기 [Article Type] Article
Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak첫 번째 지역 사회 발발 1 년 후 태국 4 개 병원에있는 의료 서비스 제공 업체들 사이에서 SARS-COV-2 감염에 대한 혈청 조사Multicenter Study Published on 2021-07-142022-09-10 Journal: PLoS ONE [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] antibodies antibody blood specimens China collected Community coronavirus disease Coronavirus disease 2019 country COVID-19 enrolled enzyme enzyme-linked immunosorbent assays examined hcp Healthcare provider healthcare providers hospital IgG Immunoglobulin Immunoglobulin G imported case infected cases nucleocapsid outbreak patients positive Prevalence Protein Result SARS-CoV-2 SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody SARS-COV-2 infection Seropositivity specimens susceptible tested the SARS-CoV-2 treated [DOI] 10.1371/journal.pone.0254563 PMC 바로가기 [Article Type] Multicenter Study
Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study기능적 체력, SARS-COV-2에 대한 항체 및 면역 지표의 역동적 인 변화 및 심각한 COVID-19를 가진 중국 의료 종사자에서 퇴원 한 후 1 년 이내에 면역 학적 지표 : 코호트 연구Research Article Published on 2021-07-142022-09-01 Journal: BMC Medicine [Category] SARS, 진단, [키워드] ANOVA antibody asked balance CD3 CD4 change China Chinese cohort study Complete conducted consequence coronavirus disease Coronavirus disease 2019 COVID-19 cytokine described discharge dynamic elevated female Fisher’s exact test flexibility follow-up visits functional group HCW HCWs Health Health care Health care worker health care workers help hospital IgG IgM IL-6 immunological Intervention Kruskal-Wallis test Lymphocyte subsets Mann-Whitney Mann-Whitney U test median median age medical staff Muscle strength not recovered Novel coronavirus Nurses participant Patient Physical examination reported Research Result SARS-CoV-2 Seropositivity severe COVID-19 Severe infection severe infections supplementary material T cell T cells T Test titre TNF-α variance were used with COVID-19 [DOI] 10.1186/s12916-021-02042-0 PMC 바로가기 [Article Type] Research Article
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects이전에 SARS-CoV-2에 감염된 피험자에 대한 장기 항체 지속성 및 탁월한 백신 접종 반응Article Published on 2021-07-132022-09-12 Journal: Vaccine [Category] MERS, SARS, 진단, [키워드] antibody COVID-19 COVID-19 vaccine dose doses exceptional first dose General population humoral immune responses immune response Immunity individuals infected individual injection mRNA vaccine normality persist persistence receive Roche Roche anti-SARS-CoV-2-S SARS-CoV-2 SARS-CoV-2 infected individual SARS-CoV-2 infected subject SARS-CoV-2 infected subjects second dose serological test Serologically seronegative seropositive individual Seropositivity single dose tested Treatment vaccination [DOI] 10.1016/j.vaccine.2021.06.020 PMC 바로가기 [Article Type] Article
Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study세르비아 북부의 SARS-COV-2 바이러스에 대한 항체의 혈청 유병률 (Vojvodina) : 4 연속 센티넬 인구 기반 조사 연구Research Article Published on 2021-07-092022-09-10 Journal: PLoS ONE [Category] SARS, 진단, 치료법, [키워드] 95% CI age anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody Asymptomatic change conducted confirmed cases Course COVID-19 COVID-19 outbreak cross-sectional Gender IgG antibodies IgG antibody immunoassay immunochromatographic immunochromatographic test indicated Infection LINE monitoring no significant difference nucleocapsid protein point-of-care population prevalence public health qualitative test Rapid test rapid test) reached repeated Result RT-PCR S1 subunit SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 virus Seropositivity Seroprevalence significant difference Spike protein subgroup subject test results the S1 subunit the spike protein total population was tested were assessed widespread [DOI] 10.1371/journal.pone.0254516 PMC 바로가기 [Article Type] Research Article